DBV Technologies SA (NASDAQ:DBVT)
| 7.80 Delayed Data As of Dec 10 |  -0.07 / -0.89%Today’s Change | 3.60 Today|||52-Week Range 16.19 | +21.50% Year-to-Date |
Latest DBVT News | Press Releases
No recent news for DBV Technologies SA.
Today’s Trading
| Previous close | 7.87 |
| Today’s open | 7.85 |
| Day’s range | 7.74 - 7.94 |
| Volume | 277,991 |
| Average volume (3 months) | 339,450 |
| Market cap | $567.0M |
Data as of 3:59pm ET, 12/10/2019
Growth & Valuation
| Earnings growth (last year) | -0.59% |
| Earnings growth (this year) | -8.89% |
| Earnings growth (next 5 years) | +34.41% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.42 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Oxford BioMedica PLC | -0.11 | -1.45% |
| BCELAtreca Inc | +1.21 | +8.59% |
| XCURExicure Inc | +0.10 | +3.46% |
| CLXTCalyxt Inc | +0.07 | +1.28% |
Data as of 4:00pm ET, 12/10/2019
Financials
| Last reporting date | March 6, 2019 |
| EPS forecast (this quarter) | -$0.72 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$195.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Montrouge, Ile-de-france |
Forecasts
